6,8-Bis(Benzylthio)Octanoic Acid, Cytarabine, and Daunorubicin Hydrochloride in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02472626 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Drug Supply Issues

Conditions

Untreated Adult Acute Myeloid Leukemia

Interventions

DRUG: 6,8-Bis(benzylthio)octanoic Acid
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]